EUVIMEDEUVIMED entdecken
Crossref

Overview of Drug Control: A Regulatory Primer on Scheduling and Controlled Substance Regulations

Jonathon M. Parker

Clinical Research and Regulatory Affairs · 2006

DOI: 10.1080/10601330601079851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research and Regulatory Affairs, 2006. Verfasst von Jonathon M. Parker. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For new chemical entities, assessing a compound's abuse potential is an important component of the drug development process. To ensure regulators make the correct evaluation of a compound's abuse liability, it is vital for pharmaceutical companies to understand the appropriate preapproval measures for assessing a new chemical entity's abuse potential and the required registration procedures for making the recommendation. The goal of this review is to present an overview of the scheduling process as it relates to drug development and marketing registration.

Zitieren

APA

Parker, J. M. (2006). Overview of Drug Control: A Regulatory Primer on Scheduling and Controlled Substance Regulations. Clinical Research and Regulatory Affairs. https://doi.org/10.1080/10601330601079851

Vancouver

Parker JM. Overview of Drug Control: A Regulatory Primer on Scheduling and Controlled Substance Regulations. Clinical Research and Regulatory Affairs. 2006. doi:10.1080/10601330601079851

BibTeX
@article{Parker2006,
  author = {Parker, Jonathon M.},
  title = {Overview of Drug Control: A Regulatory Primer on Scheduling and Controlled Substance Regulations},
  journal = {Clinical Research and Regulatory Affairs},
  year = {2006},
  doi = {10.1080/10601330601079851}
}
Kostenlos starten →